| TTM
|
5/31/2026
|
5/31/2025
|
5/31/2024
|
5/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
71,777,000 | 67,357,000 | 57,399,000 | 52,961,000 | 49,954,000 |
| Cost of Revenue
|
-25,870,000 | -23,021,000 | -16,927,000 | -15,143,000 | -13,564,000 |
|
Gross Profit
|
45,907,000 | 44,336,000 | 40,472,000 | 37,818,000 | 36,390,000 |
| Selling, General and Administrative Expenses
|
-9,698,000 | -9,949,000 | -10,253,000 | -9,822,000 | -10,412,000 |
|
Research and Development Expenses
|
-10,183,000 | -10,272,000 | -9,860,000 | -8,915,000 | -8,623,000 |
| Depreciation, Amortization and Depletion
|
-1,454,000 | -1,671,000 | -2,307,000 | -3,010,000 | -3,582,000 |
|
Operating Income/Expenses
|
-21,335,000 | -21,892,000 | -22,420,000 | -21,747,000 | -22,617,000 |
|
Total Operating Profit/Loss
|
24,572,000 | 22,444,000 | 18,052,000 | 16,071,000 | 13,773,000 |
| Total Net Finance Income/Expense
|
-4,121,000 | -3,819,000 | -3,000,000 | -3,063,000 | -3,220,000 |
| Net Investment Income
|
2,572,000 | 2,458,000 | -609,000 | -717,000 | -741,000 |
| Irregular Income/Expenses
|
-1,516,000 | -1,838,000 | -374,000 | -718,000 | -680,000 |
|
Other Income/Expense, Non-Operating
|
227,000 | 309,000 | 91,000 | 168,000 | -6,000 |
|
Non-Operating Income/Expenses, Total
|
-2,838,000 | -2,890,000 | -3,892,000 | -4,330,000 | -4,647,000 |
|
Pretax Income
|
21,734,000 | 19,554,000 | 14,160,000 | 11,741,000 | 9,126,000 |
|
Provision for Income Tax
|
-2,814,000 | -2,467,000 | -1,717,000 | -1,274,000 | -623,000 |
|
Net Income from Continuing Operations
|
18,920,000 | 17,087,000 | 12,443,000 | 10,467,000 | 8,503,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
18,920,000 | 17,087,000 | 12,443,000 | 10,467,000 | 8,503,000 |
|
Net Income after Non-Controlling/Minority Interests
|
18,920,000 | 17,087,000 | 12,443,000 | 10,467,000 | 8,503,000 |
| Preferred/Other Stock Distribution
|
-184,000 | -103,000 | 0 | 0 | -- |
|
Net Income Available to Common Stockholders
|
18,736,000 | 16,984,000 | 12,443,000 | 10,467,000 | 8,503,000 |
|
Diluted Net Income Available to Common Stockholders
|
18,736,000 | 16,984,000 | 12,443,000 | 10,467,000 | 8,503,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
25,855,000 | 23,373,000 | 17,160,000 | 14,804,000 | 12,346,000 |
|
EBITDA
|
36,736,000 | 32,667,000 | 23,334,000 | 20,943,000 | 18,454,000 |
|
Normalized EBITDA
|
40,205,000 | 36,505,000 | 28,660,000 | 25,938,000 | 23,008,000 |
|
Normalized Income
|
23,710,000 | 22,234,000 | 17,284,000 | 15,710,000 | 14,176,000 |
|
Total Unusual Items
|
3,469,000 | 3,838,000 | 5,326,000 | 4,995,000 | 4,554,000 |
|
Total Unusual Items Excluding Goodwill
|
3,469,000 | 3,838,000 | 5,326,000 | 4,995,000 | 4,554,000 |
|
Tax Effect of Unusual Items
|
449,148.78 | 483,588 | 644,446 | 544,455 | 309,672 |
|
Tax Rate, Calculated
|
0.13 | 0.13 | 0.12 | 0.11 | 0.07 |
5/31/2023 - 2/10/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade